— ASH data reinforce survival benefits of front-line AYVAKIT® (avapritinib) use in patients with advanced SM — — Bone density analyses reported in patients with advanced SM underscore disease-modifying effects of AYVAKIT — CAMBRIDGE, Mass., […]
Tag: Blueprint Medicines Corporation
